3) the status of using medicine
用药状况
1.
Result:blood--vessel,depression,parkisen s illness,falling sickness are the distrease which have most patients; the status of using medicine is affected by many factors,such as the patient s age,gender,family,work.
方法:运用回顾调查的方法,对150例患者的用药状况和影响因素进行对比分析。
4) present application
应用现状
1.
This thesis narrates and comments on the present development of Chinese drying technology, the research of drying theory and the technical innovation; gives a complete introduction of the drying technology's present application in various professions; analyses and discusses the permanent development path and the development tendency of drying technology.
对中国干燥技术、干燥理论研究及技术创新的发展现状作了评述;对干燥技术在各行业的应用现状作了全面介绍;对干燥技术的可持续发展道路与发展趋势作了分析与探讨。
2.
In the paper is described the reserves,production,price and present applications of Indium is described.
介绍了铟的储量、生产情况和价格,分析了铟的应用现状,预测了铟的应用发展前景。
3.
The photocatalytic mechanism of nano- TiO2 was investigated, a nd factors affecting its photocatalytic performance, such as crystal structure, cr ystal size, surface modification and compounding were analyzed with its present applications as photocatalyst in environment protection, bacteria killing and at tacking, photovoltaic conversion and so on being summarized.
综述了目前TiO2光催化剂在环境保护、杀菌抗菌、光电转换等方面的应用现状。
5) application status
应用现状
1.
The Germ Plasm Resources of Hosta in China and its Application Status in Landscape Architecture;
玉簪属植物种质资源及其园林应用现状
2.
The application status and countermeasures of tree species for landscapes in Tangshan city;
唐山市园林绿化树种应用现状及对策
3.
The application status and outlook of wavelets analysis;
小波分析的应用现状及展望
6) application
[英][,æplɪ'keɪʃn] [美]['æplə'keʃən]
应用现状
1.
Study of magnesium phosphate cementitious and recent development of its application;
化学结合磷酸镁胶凝材料的研究及应用现状
2.
Application and Value-added Specialty Product Development of Oriented Strand Board;
定向刨花板的应用现状与增值加工
3.
Study on Silane Agents and its New Application for Metal Surface Treatment;
硅烷偶联剂应用现状及金属表面处理新应用
补充资料：5FU联合用药方案
5FU联合用药方案
主要用于滋养细胞肿瘤晚期(ⅢB和Ⅳ期)病人，通常两药合用。5FU加KSM(更生霉素)或5FU加AT1258(消瘤芥)。联合用药时5FU用量减至每天每千克体重26mg左右，KSM用量为每天每千克体重6μg(一般每天用300μg)，分别溶于1000ml 5%葡萄糖溶液中，先滴5FU，完后用KSM。5FU加AT1258方案：AT1258 1次用量20～30mg，5FU每千克体重26mg，先静脉注射AT1258再滴5FU，两药合用8天为一疗程。间隔为3周。对耐药病人，如耐药原因是5FU用药量偏小，则常用5FU加KSM加AT1258三药联合应用，其剂量与二药联合方案相同。必要时三药方案与长春新碱合用，先用长春新碱1～2mg，再依次用AT1258，5FU和KSM，三药剂量不减，但疗程缩短至5～6天。疗程间隔为4周，依不良反应消退时间而定。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条